The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Pediatric Cancer Survivors: Past History and Future Challenges, Anna T. Meadows
Late Effects of Treatment for Cancer During Childhood and Adolescence, Daniel Green
Neurocognitive Late Effects in Pediatric Cancer, Raymond Mulhern
Quality of Life Issues and Cancer Survivorship, Brad Zebrack and Lonnie Zeltzer
Research Involving Long Term Survivors of Childhood and Adolescent Cancer: Methodologic Considerations, Leslie Robison
Cancer Survivorship: Issues Impacting Design and Conduct of Clinical Trials, Sharon Murphy
Longitudinal Cancer-Related Health Care for Adult Survivors of Childhood Cancer, Kevin Oeffinger
Cognitive Late Effects of Childhood Cancer and Treatment: Issues for Survivors, F. Daniel Armstrong,
Long-term Survivor Programs: A Paradigm for the Advanced Practice Nurse, Alice G. Ettinger
The Board heard from the following cancer survivorship specialists and representatives of federal agencies at the Board’s quarterly meeting in July 2001:
Anna T. Meadows, MD, The Children’s Hospital of Philadelphia, provided an overview of childhood cancer survival;
Daniel Green, MD, Roswell Park Cancer Institute, discussed late effects of treatment for childhood cancer;
Raymond Mulhern, PhD, St. Jude Children’s Research Hospital, described neurocognitive late effects in pediatric cancer;
Leslie Robison, PhD, University of Minnesota Cancer Center, described epidemiologic and research issues;
Sharon Murphy, MD, Children’s Memorial Hospital, Chicago, reviewed clinical trial issues in survivorship research;
Lonnie Zeltzer, MD, David Geffen School of Medicine at UCLA discussed psychosocial and behavioral outcomes in childhood cancer; and
Julia Rowland, PhD, Director of the National Cancer Institute Office of Cancer Survivorship discussed federal research initiatives in childhood survivorship.
Perspectives on health care delivery were discussed at the January 2002 meeting where the Board heard from:
Kathy Ruble, RN, and Cindy Schwartz, MD, of the Johns Hopkins Pediatric Oncology Program;